Vipin Kumar Chaturvedi
Technik-/Wissenschafts-/F&E-Leiter bei GRI BIO, INC.
Vermögen: 353 $ am 30.04.2024
Profil
Vipin Kumar Chaturvedi is the founder.
He founded Simomics Ltd.
in 2015, where he held the title of Non-Executive Director from 2015 to 2022.
Dr. Chaturvedi's current job is as the Chief Scientific Officer at GRI Bio, Inc. since 2023.
Dr. Chaturvedi's former job was as the Chief Scientific Officer at Vallon Pharmaceuticals, Inc. He also worked as a Professor at the University of California San Diego from 2022 to 2023.
Dr. Chaturvedi obtained a doctorate degree from the Indian Institute of Science and an undergraduate degree from Chhatrapati Shahu Ji Maharaj University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GRI BIO, INC.
0,02% | 21.04.2023 | 820 ( 0,02% ) | 353 $ | 30.04.2024 |
Aktive Positionen von Vipin Kumar Chaturvedi
| Unternehmen | Position | Beginn |
|---|---|---|
| GRI BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2023 |
Ehemalige bekannte Positionen von Vipin Kumar Chaturvedi
| Unternehmen | Position | Ende |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 01.03.2023 |
Simomics Ltd.
 Simomics Ltd. Packaged SoftwareTechnology Services Simomics Ltd. is a British company that develops integrated cloud-deployed evidencing tools. | Gründer | 01.07.2022 |
| GRI BIOPAR | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Vipin Kumar Chaturvedi
| Indian Institute of Science | Doctorate Degree |
| Chhatrapati Shahu Ji Maharaj University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GRI BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Simomics Ltd.
Simomics Ltd. Packaged SoftwareTechnology Services Simomics Ltd. is a British company that develops integrated cloud-deployed evidencing tools. | Technology Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
